Analysts say these top ASX growth shares are buys
Cochlear Limited (ASX:COH) and this ASX growth share are rated as buys by analysts right now. Here's why...
Stay updated with breaking news from Cochlear Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cochlear Limited (ASX:COH) and this ASX growth share are rated as buys by analysts right now. Here's why...
Press release content from Business Wire. The AP news staff was not involved in its creation.
Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent
Regulatory News: Sensorion ALSEN (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of nove
Biotech and health tech stocks have suffered greatly in recent months. But one fund manager is sticking by 2 particular businesses.